Poster Session: Session 1: Gastrointestinal autoimmunity
P1-032 PANCREATIC MAJOR ZYMOGEN MEMBRANE GLYCOPROTEIN2 ( MZGP2) IGG AND IGA AUTOANTIBODIES ARE SPECIFIC MARKERS FOR THE DETECTION OF CROHN'S DISEASE
G.L. Norman1, Z. Shums1, P. Pavlidis2, A. Forbes3, D.P. Bogdanos2
1R & D, INOVA Diagnostics Inc., San Diego, USA
2School of Medicine, Kings College Hospital, London, United Kingdom
3Gastroenterology and Clinical Nutrition, University College Hospital, London, United Kingdom
Introduction: ASCA (anti-Saccharomyces cerevisiae antibody) and ANCA (antineutrophil cytoplasmic antibody) assays are used to aid the non-invasive differentiation of Crohn's Disease (CD) and ulcerative colitis (UC). ASCA has sensitivity of 50-65% for CD and ANCA a sensitivity of 45-70% for UC. Up to 30% of CD patients have antibodies to structures in the exocrine pancreas. These antibodies are mainly directed against the major zymogen granule membrane glycoprotein2 (MZGP2).
Aim: Evaluate the performance of QUANTA Lite® MZGP2 IgG and IgA ELISA assays (RUO, INOVA Diagnostics) in IBD patients and controls.
Methods: Sera from a well-characterized IBD cohort from University College Hospital, London, (125 CD and 123 UC) were tested on Quanta Lite® MZGP2 IgG and IgA ELISAs. Controls included 103 healthy and 112 disease controls.
Results: MZGP2 IgG was detected in 33/125 (26%) and MZGP2 IgA in 17/125 (14%) of the CD patients. MZGP2 IgG and IgA were positive in 4/123 (3.2%) and 5/123 (4%) of the UC patients respectively. MZGP2 IgG and IgA were detected in 7/215 (3.2%) and 6/215 (2.8%) of the healthy and disease controls, respectively. Adding MZGP2 IgG/IgA to ASCA testing increased overall sensitivity for Crohn's disease to 72%, uniquely detecting 5/125 (4%) CD patients.
Conclusion: The QUANTA Lite® MZGP2 IgG and IgA ELISAs contributed to the differential diagnosis of CD in IBD with a sensitivity of 26% including the unique identification of 4/82 (4.9%) CD patients. Adding MZGP2 to the traditional panel of serological markers may help to accurately detect more CD patients using non-invasive methods.
P1-033 CHRONIC GASTRITIS AS THE GASTROINTESTINAL MANIFESTATION IN SYSTEMIC VASCULITIS
A. Kurniawan1, N. Lugito1, M. Tjiang1, I. Wijaya1, T. Yanto1, R. Setiawan1
1Internal medicine, University of Pelita Harapan, Jakarta, Indonesia
Introduction
Vasculitis can cause local or diffuse pathologic changes in the gastrointestinal tract, resulting in nonspesific paralytic ileus, mesenteric ischemia, submucosal edema and hemorrhage, or bowel perforation or stricture. Sytemic vasculitis is known to affect the gastrointestinal tract but the nature of the complication is poorly charaterized.
Case report
We reported a 48 year old man came with multiple ulcer in mouth and right leg. He also felt fever, erythema in his left eye, epigastric pain, black ter like feces, and decrease his body weight. He did not complaint about edem in his leg or others place. From physical examination revealed redness in his left eye with loss his sight, muliple ulcer in buccal, epigastric pain, ulcer in his leg with 3-4 cm in diameter with no pus. From the laboratoy results showed normocytic normochromic anemia, leukocytosis with netrophilia, increased D-dimer, hypoalbuminemia, ANA positive with speckled pattern; complement C3/C4 was 76,4/140. Skin biopsy of leg ulcer showed vasculitis. Gastroscopy result showed erosive gastritis and colonoscopy result showed multiple ulcer in colon. Result of biopsy of gastric showed the presence of vasculitis which patohological anatomic result revealed signs of erythrocyte extravacation. He was given methyl prednisolon at immunosuppresant dose, oral anticoagulant with prophylactic dose, proton pump inhibitor and acyclovir. The ulcers were resolved after one month follow up.
Key Words: Systemic vasculitis, multiple ulcer, non active chronic gastritis
P1-034 PLUMMER VINSON SYNDROME-A CASE REPORT
D. Madi1, S. Yadalpati1
1Medicine, MANIPAL UNIVERSITY, mangalore, India
Plummer Vinson syndrome represents the classical association of post cricoid dysphagia, upper oesophageal webs and iron deficiency anemia . Plummer Vinson Syndrome is a rare cause of dysphagia. Proposed etiologic factors are iron, nutritional deficiencies and autoimmunity.
A 46 year old female presented to our hospital, with complaints of easy fatiguability and dysphagia of one year duration. Clinical examination revealed pallor and platynychia.
Her investigations showed haemoglobin of 5.6gm%(11-15 gm%), Serum Ferritin - 1.55 ng/ml and peripheral smear - microcytic, hypochromic anemia. Barium swallow (Figure 1) and UGI scopy was done which showed a mucosal web causing luminal compromise.Endoscopic dilation of the web was done. She was transfused with 2 units of packed cells.Iron supplements were given.
A diagnosis of Plummer Vinson syndrome should be considered in any person presenting with iron deficiency anemia and dysphagia because prognosis of Plummer-Vinson syndrome is excellent and it is a reversible cause of dysphagia.
P1-035 CALPROTECTIN AND ANCA IN NEUTROPHIL-MEDIATED IBD
I. Lochman1, A. Lochmanová2, J. Martinek3, H. Tomaskova4, I. Bártková5, P. Svoboda6, V. Smajstrla7
1Immunology, Spadia Lab Ltd, Ostrava, Czech Republic
2Department of Biomedical Sciences, Faculty of Medicine University of Ostrava, Ostrava, Czech Republic
3Immunology and Allergy, Institute of Public Health, Ostrava, Czech Republic
4Department of epidemiology and Public Health, Faculty of Medicine University of Ostrava, Ostrava, Czech Republic
55Department of Pediatrics, Municipal Hospital, Ostrava
66Department of Clinical Studies, Faculty of Medicine, University of Ostrava
77Bormed, Ltd., Ostrava, Czech Republic
Determination of faecal calprotectin and ANCA are used in the diagnosis and laboratory monitoring of inflammatory bowel diseases - IBD (Crohn's disease, ulcerative colitis and neoplasms). Both analytes are associated with an inflammatory process which involves neutrophils, but the information obtained from these tests is not completely identical.
We analyzed the results of faecal calprotectin using Quantum blue (Buehlmann) and ELISA (R-Biopharm) kits and ANCA determination using IFA CIBD-Profile 1 kits (Euroimmun) containing chips with ethanol-fixed granulocytes and IgG conjugate in our labs during 2011 and 2012. Overall, 1088 samples from 823 patients have been analyzed for calprotectin and ANCA and 4723 samples only for ANCA using IFA CIBD-Profile 1 kits.
Detailed analysis of results confirmed that the levels of both analytes correlate with the intensity of neutrophil-mediated inflammation. We demonstrate it on several case reports. The vast majority of total ANCA was designated as A-ANCA, possibly GS-ANA after typing, but it was difficult or impossible to distinguish these antibodies in the presence of other antinuclear antibodies in some cases.
However targets against which these antibodies are formed, are mostly NETs epitopes (neutrophil extracellular traps) that is difficult, if not impossible, to define generally. Eventhough IFA on ethanol-fixed granulocytes is generally recommended for ANCA screening, it has not been uniquely accepted legal diagnostic scheme for ANCA screening and their subsequent typing. Especially for diseases other than ANCA associated vasculitis (AAV) can be obtained frequently confused results between IFA and other immunoassays that use defined neutrophil cytoplasmic substrates.
P1-036 THE TETRASPANIN CD151 AS A NOVEL REGULATOR OF T CELL MOTILITY IN HEALTH AND INFLAMMATORY BOWEL DISEASE
E. Toister-Zelman1, E. Bakos1, S. Cohen1, E.H.U.D. Zigmond1, V. Grabovsky1, A.D.I. Sagiv1, G.I.L.I. Hart1, N. Kaushansky1, A.V.I. Ben-Nun1, A. Sonnenberg1, R. Alon1, I.D.I.T. Shachar1
1Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel
The continuous recirculation of mature lymphocytes and their entry into the peripheral
lymph nodes (LNs) are crucial for the development of an effective immune response.
Picomolar (pM) levels of CCL2 were previously shown to inhibit T cell migration to LNs
resulting in reduced inflammation. However, the molecular mechanisms regulated by low
dose CCL2 remained unknown. In this study, we demonstrate that the tetraspanin CD151 is a target
of CCL2 in T cells. pM levels of CCL2 downregulated CD151 expression and dissociated
CD151/VLA-4 and CD151/LFA-1 complexes in T lymphocytes, resulting in their attenuated
migration. Ablation of CD151 expressed on immune cells reduced inflammation in a DSS
induced colitis model of CD151-/- chimeric mice. Moreover, blocking of CD151, using CD151
truncated peptide fragment, reduced cell migration in vitro and in vivo, and inhibited the
development of DSS-induced colitis. Thus, CD151 is a novel orchestrator of T cell motility,
and its targeting by inhibitory peptides results in beneficial suppression of inflammation.
Poster Session: Session 1: Genetics and autoimmunity
P1-037 ASSOCIATION OF INTERLEUKIN-10 -1082A/G POLYMORPHISM IN BULGARIAN PATIENTS WITH AS AND RA
M. Ivanova1, I. Manolova2, A. Avramova3, N. Stoilov1, R. Stoilov1, R. Rashkov1, S. Stanilova3
1Clinic of Rheumatology, University Hospital "Sv. Iv. Rilski", Sofia, Bulgaria
2Department of Health Care, Medical Faculty Trakia University, Stara Zagora, Bulgaria
3Department of Molecular Biology Immunology and Medical Genetics, Medical Faculty Trakia University, Stara Zagora, Bulgaria
Background: IL-10 is an important regulatory cytokine with a significant role in autoimmune diseases. The promoter polymorphism in IL-10 gene (IL10), located at -1082 A/G (rs1800896) has an impact on IL-10 production. Studies on the relationship of IL-10 rs1800896 polymorphism with RA and AS are inconclusive.
Objective: To investigate whether IL10 rs1800896 enables development of AS and RA in Bulgarian population.
Patients and methods: Genotyping for -1082A/G polymorphism in IL10 was performed by allele specific PCR. 58 patients with AS and 56 with RA were compared with 106 and 88 matched healthy subjects, respectively.
Results: No association between the rs1800896 polymorphism and RA risk was established under the additive model (allele A vs allele G; OR=0.99), the codominant model (AA vs. GG; OR=1.061), the dominant model (AA+AG vs. GG; OR=1.13) and the recessive model (AA vs. AG+GG; OR=1.08). An association between AS and rs1800896 polymorphism in the same genetic models (additive: OR=1.374, 95%CI=0.83ü2.27, p=0.19; codominant: OR=1.607, 95%CI=0.519ü5.095, p=0.51; dominant: OR=1.201, 95%CI =0.42ü3.5, p=0.89; recessive: OR=0.59, 95%CI=0.29ü1.19, p=0.113) was found. These results suppose that AA genotypes could be predisposing, whether GG genotypes might be protective for susceptibility to AS. Moreover, significant associations were observed in AS for age at disease onset (age at onset <29; OR=2.769, 95%CI =0.836ü9.382, p=0.06) and functional outcome (BASFI score>4; OR=3.956, 95%CI =1.137ü14.245, p=0.014).
Conclusion: Promoter polymorphism -1082A/G in IL-10 gene has no significant effect on RA development, but could play a role in AS, mostly determining age of disease onset and disease severity in Bulgarian patients.
P1-038 THE RELATIONSHIP BETWEEN SYSTEMIC LUPUS ERYTHEMATOSUS AND CLEC16A, A PUTATIVE NOVEL C-TYPE LECTIN-LIKE PROTEIN
R. Tam1, S. Yan1, W.C.S. Lau1, S.F.V. Chan1
1Medicine, The University of Hong Kong, Hong Kong, Hong Kong China
Several independent genome wide association studies have shown associations of single nucleotide polymorphisms within the C-type lectin domain family 16 member A gene, CLEC16A, with various autoimmune diseases, including systemic lupus erythematosus (SLE). However, the expression and function of this novel C-type lectin domain-containing protein is still largely unknown. This study aimed to relate its expression level in peripheral blood mononuclear cells (PBMCs) with SLE disease activity. Two expressed isoforms, isoforms 1 and 2, of CLEC16A were cloned and sequenced from PBMCs from healthy Chinese. Surprisingly, both sequences of isoforms 1 and 2 bore differences when compared to the reference sequences derived from Caucasians. In isoform 1, exon 5 was consistently absent in Chinese PBMCs. However, in isoform 2, the stretch of 48-bp in-frame deletion within exon 11 in the reference sequence was found present in Chinese PBMCs. The mRNA expression levels of both isoforms were found significantly lower in SLE patients than in normal individuals. Yet, their expression levels did not correlate with disease activity as measured by SLE disease activity index. The molecular and cellular functions of CLEC16A are currently under investigation, which should shed light on the importance of this protein in SLE pathogenesis.
P1-039 ASSOCIATION OF +3179 A/G IGF-1R POLYMORPHISM WITH RHEUMATIC DISEASES (RA AND AS)
S. Stanilova1, M. Ivanova2, I. Karakolev1, R. Stoilov2, R. Rashkov2, I. Manolova3
1Department of Molecular Biology Immunology and Medical Genetics, Medical Faculty Trakia University, Stara Zagora, Bulgaria
2Clinic of Rheumatology, University Hospital "Sv. Iv. Rilski", Sofia, Bulgaria
3Department of Health Care, Medical Faculty Trakia University, Stara Zagora, Bulgaria
Background: The insulin-like growth factor (IGF) system plays a prominent role in the regulation of immunity and inflammation. Inappropriate balance of the IGF-1 signalling has been reported in autoimmune disorders. A few previous studies have investigated the modulation of the IGF signalling pathway in the rheumatic diseases, but their findings are controversial. Recently, single nucleotide polymorphism (SNP) located in exon 16 (+3179G/A; rs2229765) of IGF-1R gene was found associated with serum levels of IGF-I and human longevity.
Aim: To compare +3179G/A IGF-1R genotype distribution in rheumatoid arthritis (RA) and ankylosing spondylitis (AS).
Patients and methods: Genotyping for +3179G/A polymorphism was performed by restriction fragment length polymorphisms (RFLP)-PCR assay in 70 patients with RA, 55 with AS and corresponding age and sex matched healthy donors.
Results: We found an opposite effect of the investigated IGF-1R polymorphism (+3179G/A; rs2229765) on disease susceptibility to RA and AS. Significant differences in allele and genotype frequencies between RA and healthy controls were observed: higher frequency of homozygous genotype AA (22.9% vs14.1%; OR= 2.33, p=0.034) and allele *ÒAÓ (47.9% vs37.5%; OR= 1.53, p=0.032) in cases versus controls. Although the genotype frequencies in AS in comparison with healthy controls were not significantly differing, the lowest frequency of AA genotype was observed in AS (10.9% vs 20,9%; OR= 0,47; p=0.142).
Conclusions: Allele A and genotype AA of +3179G/A IGF-1R polymorphism are associated with RA genetic predisposition, but it seems as a protective factor for AS. Our data confirm the involvement of the IGF-1 signal pathway in RA.
P1-040 SUSCEPTIBILITY OF TNFAIP3 GENE POLYMORPHISMS TO RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS IN KOREAN POPULATION
S.K. Kim1, J.Y. Choe1, S.H. Park1, H. Lee1, K.Y. Park2, J.H. Kim2
1Rheumatology, Daegu Catholic university Hospital, Daegu, Korea
2Arthritis and Autoimmunity Research Center, Daegu Catholic university Hospital, Daegu, Korea
Objective: We investigated polymorphisms of TNFAIP3 gene to genetic susceptibility of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Korean population.
Methods: Study participants included 422 patients with RA, 133 patients with SLE, and 422 healthy controls in this case-control study. Genotyping for rs5029941(C>T), rs2230926(T>G), rs5029930(C>A), rs5029937(G>T), rs5029939(G>C) in TNFAIP3 gene polymorphisms were performed. Status of RA-related autoantibodies including rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) in RA and presentations of arthritis or nephritis in SLE were assessed.
Results: Significantly different frequencies of minor alleles in two TNFAIP3 polymorphisms in SLE patients were noted, in comparison to healthy controls (OR 2.13, 95% CI 1.25-3.65, p = 0.02 for rs5029937; OR 2.17, 95% CI 1.27-3.72, p = 0.01 for rs5029939). In addition, SLE patients showed different frequencies of haplotypes compared to healthy controls (p < 0.001). However, lack association between RA susceptibility and TNFAIP3 polymorphisms was identified (p = 0.28). Interaction between RA-related autoantibody status and TNFAIP3 polymorphisms was not associated with RA susceptibility. Interestingly, appearance of arthritis in SLE seemed to be marginally related with TNFAIP3 polymorphisms (p = 0.04).
Conclusion: Our study suggests that TNFAIP3 gene polymorphism may be related with differential susceptibility to SLE and RA in Korean population. It implicates that TNFAIP3 gene polymorphism to RA susceptibility might be dependent on individual ethnics.
P1-041 AUTOSOMAL DOMINANT HYPERIMMUNOGLOBULIN E SYNDROME IN A 9 YEAR OLD BOY
A. Lubis1, R. Akbar1, Z. Hikmah1, A. Endaryanto1, A. Harsono1
1Child health, Airlangga University, Surabaya, Indonesia
Background: The autosomal dominant hyperimmunoglobulin E syndrome is a rare primary immunodeficiency that difficult to diagnose, because this disease has multisystem disorder.
Aims: To present a case of autosomal dominant hyperimmunoglobulin E syndrome in a 9 year old boy
Case report: A 9 year old boy with immunologic manifestation: skin cold abscesses, eczematous, excoriated, lichenification, reccurent cutaneous infection, bilateral benign chronic suppurative middle otitis, bronchopneumonia, and septicemia with blood culture result was Staphylococcus Aureus and skin culture result were Staphylococcus Aureus and Pseudomonas Aeruginosa. Total immunoglobulin E were elevated (18,000 IU/ml and 50,000 IU/ml) and eosinophils count 3,000 cells/ml. Non immunologic manifestation: coarse facial features, prominent forehead and chin, broad nose, retained primary teeth, delayed bone age and also cardiac involvement. Based on United States national health institute scoring system with clinical and laboratory test for individuals in kindreds with hyperimmunoglobulin E syndrome the score is 53 and suggestive of autosomal dominant hyperimmunoglobulin E syndrome. The treatment were supportive, antibiotics based on culture result and intravenous gammaglobulin were given
Conclucions: Autosomal dominant hyperimmunoglobulin syndrome is a rare primary immunodeficiency that has multisystem disorder with immunologic and non immunologic manifestation. Clinicians must depend on recognizing this multisystem disorder and clinical features which develop over years, thereby making the diagnosis of hyperimmunoglobulin E syndrome is difficult.
Keywords: Autosomal dominant hyperimmunoglobulin E syndrome, multisystem disorder
P1-042 SHARED AND DISTINCT GENETIC RISK FACTORS OF AUTOIMMUNE DISEASES
D. Chang1, A. Keinan1
1Biological Statistics and Computational Biology, Cornell University, Ithaca, USA
The shared pathogenesis between autoimmune diseases has been explored through comorbidity studies. Genome-wide association studies (GWAS), which compare genetic data between cases and controls, provide support of many genetic risk factors shared between diseases. Studies have specifically explored this shared pathogenesis via GWAS summary statistics alone; such as testing the correlation of association signals between pairs of autoimmune diseases across many SNPs. Here we introduce a new method that rigorously explores the shared genetic risk between autoimmune diseases and between them and diseases of other classes. Our method applies principal component analysis (PCA) to a matrix of gene-level significance scores across many GWAS datasets, while correcting for confounders such as genotyping arrays and sample size. We applied our method to 30 datasets, of which 14 are autoimmune diseases. Other disease categories include psychiatric, neurological and cancers. We report several findings: 1) different studies of the same diseases generally lie closer together. 2) Inflammatory bowel diseases cluster together away from other autoimmune diseases. 3) Some psychiatric disorders cluster with autoimmune diseases. 4) Genes that underlie the observed structure are significantly enriched for immune related pathways such as IL1-mediated signaling. Prompted by our findings, we carried out a GWAS with combined cases of bipolar and type-1 diabetes (T1D). We found an association near the gene PTPRM, which presents a new association to T1D. In summary, our method offers novel findings regarding the shared pathogenetics of autoimmune diseases.
P1-043 A POLYMORPHISM (RS6457617) BETWEEN HLA-DQB1 AND HLA-DQA2 WAS ASSOCIATED WITH RHEUMATOID ARTHRITIS: A REPLICATION STUDY IN A CHINESE HAN POPULATION
H. Li1, Y.H. Hu2, X.M. Su1, Y.J. Zhu1, T. Zhang1, Y. Liu3, Y.T. Wang3, T. Yang3, M.H. Li3, Q.L. Luo1, Y. Cheng1, Q. Zou3
1Department of oncology, Chengdu Military General Hospital, Chengdu, China
2Department of traditional Chinese medicine, Chengdu Military General Hospital, Chengdu, China
3Department of immunology, Chengdu Medical College, Chengdu, China
Background and aims: Previous genome-wide association study by WTCCC identified rheumatoid arthritis (RA) susceptibility loci in British. Here, we recruited 1894 subjects to investigate whether the three SNPs with strong RA association signal in British was associated with RA in Han Chinese. Methods: We analyzed the three SNPs in Han Chinese population based on the HCB data of HapMap. The rs6679677 does not exist in Han Chinese. Other two SNPs (rs6457617 and rs11761231) were performed case-control study in the test cohort of 380 subjects firstly and the positive result was further replicated in another validation cohort of 1514 subjects. Results: In the test cohort, only rs6457617 was significantly associated with RA. The individuals bearing the homozygous genotype CC had 0.39-fold risk than these bearing the wild-type genotype TT (P = 0.004, OR 0.39, [95%CI 0.21-0.74]). And the protective effect of allele C was confirmed in combined analysis with test and validation cohort(Pgenotye CC/TT = 9.4*10-12, OR 0.35, [95% CI 0.26-0.47], Table). Conculsions: The rs6457617, which locates between the HLA-DQB1 and HLA-DQA2 encoding β chain of MHC-II protein, was also associated with RA in Han Chinese.
Table. Validation of rs6457617 in test cohort, validation cohort and combined analysis
rs6457617
|
geno- type
|
subjects no.(%)
|
|
codominant genetic model
|
controls
|
|
cases
|
|
OR (95% CI)
|
P
|
Test cohort
|
TT
|
68 (37.0)
|
|
97 (52.4)
|
|
1 (ref)
|
-
|
|
CT
|
82 (44.6)
|
|
69 (37.3)
|
|
0.59 (0.38-0.92)
|
0.02
|
|
CC
|
34 (18.5)
|
|
19 (10.3)
|
|
0.39 (0.21-0.74)
|
0.004
|
validation cohort
|
TT
|
263 (35.7)
|
|
353 (48.2)
|
|
1 (ref)
|
-
|
|
CT
|
340 (46.1)
|
|
319 (43.5)
|
|
0.70 (0.56-0.87)
|
1.0×10-3
|
|
CC
|
134 (18.2)
|
|
61 (8.3)
|
|
0.34 (0.24-0.48)
|
5.9×10-10
|
combined samples
|
TT
|
331 (35.9)
|
|
450 (49.0)
|
|
1 (ref)
|
-
|
|
CT
|
422 (45.8)
|
|
388 (42.3)
|
|
0.68 (0.56-0.82)
|
1.1×10-4
|
|
CC
|
168 (18.3)
|
|
80 (8.7)
|
|
0.35 (0.26-0.47)
|
9.4×10-12
|
Share with your friends: |